Mechanistically, the dichotomous pathway activation—immune/ECM remodeling in GPD1L-low versus metabolic regulation in GPD1L-high tumors (Figure 5)—suggests GPD1L modulates tumor-stroma crosstalk. The gene discussed is GPD1L; the disease is neoplasm.